Presentation is loading. Please wait.

Presentation is loading. Please wait.

Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:2184- 92.

Published byBartholomew Barnett Modified over 9 years ago

Similar presentations

Presentation on theme: "Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:2184- 92."— Presentation transcript:

1 Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:2184- 92

2 Demographic Characteristics of the Study Population - Part II Jenny N.Poynter et al N Engl J Med 2005;352:2184- 92

3 Crude and Adjusted Associations between Statin Use and the Risk of Colorectal Cancer in the Unmatched Study Population Jenny N.Poynter et al N Engl J Med 2005;352:2184- 92

4 Effect of Statins on the Risk of Colorectal Cancer, Colon Cancer,and Rectal Cancer in Matched Pairs Jenny N.Poynter et al N Engl J Med 2005;352:2184- 92

5 Crude and Adjusted Associations between the Use of Statins and Aspirin or Other NSAIDs and the Risk of Colorectal Cancer Jenny N.Poynter et al N Engl J Med 2005;352:2184- 92

6 Association between Statin Use and the Risk of Colorectal Canceramong Participants with Hypercholesterolemia,Ischemic Heart Disease, or Inflammatory Bowel Disease Jenny N.Poynter et al N Engl J Med 2005;352:2184- 92

Download ppt "Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:2184- 92."

Similar presentations

Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165: 2264-2271.

Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165:
Nonsense Mutations in PCSK9 and Cardiovascular Risk Factors among 3363 Black Participants in the Study Jonathan C.Cohen, et al, N Engl J Med 2006;354:1264-72.

Nonsense Mutations in PCSK9 and Cardiovascular Risk Factors among 3363 Black Participants in the Study Jonathan C.Cohen, et al, N Engl J Med 2006;354:
Frank B. Hu et al N Engl J Med 2004; 351: 2694- 703 Body-Mass Index and Relative Risk of Death from All Causes during 24 Years of Follow-up.

Frank B. Hu et al N Engl J Med 2004; 351: Body-Mass Index and Relative Risk of Death from All Causes during 24 Years of Follow-up.
Zacho J, et al. N Engl J Med 2008;359:1897-908 Risk of Ischemic Heart Disease as a Function of Plasma Levels of C-Reactive Protein (CRP) in the General.

Zacho J, et al. N Engl J Med 2008;359: Risk of Ischemic Heart Disease as a Function of Plasma Levels of C-Reactive Protein (CRP) in the General.
Characteristics of new users of statins in the period 1991–2004 in the PHARMO population F.J.A. Penning-van Beest, et al. European Heart Journal 2007;28:154–159.

Characteristics of new users of statins in the period 1991–2004 in the PHARMO population F.J.A. Penning-van Beest, et al. European Heart Journal 2007;28:154–159.
Lars Sjöström et al N Engl J Med 2004; 351: 2683- 93 Characteristics of the Subjects at the Time of Matching and at the Time of the Inclusion Examination.

Lars Sjöström et al N Engl J Med 2004; 351: Characteristics of the Subjects at the Time of Matching and at the Time of the Inclusion Examination.
Solomon Tesfaye et al N Engl J Med 2005;352:341- 50 Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.
Correlational Studies for Drug Effects Alec Walker October 2014 1.

Correlational Studies for Drug Effects Alec Walker October
Basic Characteristics of the Study Population Identified in Pennsylvania Medicare and Pharmaceutical Assistance Contract for the Elderly, 1994–2000 Soko.

Basic Characteristics of the Study Population Identified in Pennsylvania Medicare and Pharmaceutical Assistance Contract for the Elderly, 1994–2000 Soko.
Shalev V, et al. Arch Intern Med 2009; 169:260-268.

Shalev V, et al. Arch Intern Med 2009; 169:
ACE inhibitors, ARBs and Statins in COPD: High- and Low-Risk Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60.

ACE inhibitors, ARBs and Statins in COPD: High- and Low-Risk Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:
Charlotte Kragelund et al N Engl J Med 2005;352:666- 75 Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.

Charlotte Kragelund et al N Engl J Med 2005;352: Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.
Process of study selection F. Sofi, et al. BMJ 2008 Sep 11;337:a1344.

Process of study selection F. Sofi, et al. BMJ 2008 Sep 11;337:a1344.
Predictive value of CRP vs LDL-C (i) Ridker PM, et al. N Engl J Med 2002;347:1557-1565. Quintile of CRP (mg/L)

Predictive value of CRP vs LDL-C (i) Ridker PM, et al. N Engl J Med 2002;347: Quintile of CRP (mg/L)
Am J Gastroenterol 2012; 107:1213–1219 12 June 2012 R3. 김동희 /prof. 이창균.

Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.
GI Path Exam 2. Most common neoplastic polyp? Most common location and size of colonic hyperplastic polyps?

GI Path Exam 2. Most common neoplastic polyp? Most common location and size of colonic hyperplastic polyps?
Structure of Cis and Trans Fatty Acids

Structure of Cis and Trans Fatty Acids
Baseline Characteristics of the Patients Part I

Baseline Characteristics of the Patients Part I
Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.
Characteristics of the Folic Acid and Placebo Groups at the Start of the Study J. Durga et al. Arch Intern Med. 2005;165:1388-1394.

Characteristics of the Folic Acid and Placebo Groups at the Start of the Study J. Durga et al. Arch Intern Med. 2005;165:

Similar presentations

Ads by Google